Göran Stenman

Prof. Göran Stenman

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2009 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
MPMarta Persson
Marta Persson
YAYwonne Andrén
Ywonne Andrén
JMJoachim Mark
Joachim Mark
HHHugo M. Horlings
Hugo M. Horlings
FPFredrik Persson
Fredrik Persson
GSGöran Stenman
Göran Stenman
The transcription factor gene MYB was identified recently as an oncogene that is rearranged/duplicated in some human leukemias. Here we describe a new mechanism of activation of MYB in human cancer involving gene fusion. We show that the t(6;9)(q22–23;p23–24) translocation in adenoid cystic carcinomas (ACC) of the breast and head and neck consistently results in fusions encoding chimeric transcripts predominantly consisting of MYB exon 14 linked to the last coding exon(s) of NFIB . The minimal common part of MYB deleted as the result of fusion was exon 15 including the 3′-UTR, which contains several highly conserved target sites for miR-15a/16 and miR-150 microRNAs. These microRNAs recently were shown to regulate MYB expression negatively. We suggest that deletion of these target sites may disrupt repression of MYB leading to overexpression of MYB-NFIB transcripts and protein and to activation of critical MYB targets, including genes associated with apoptosis, cell cycle control, cell growth/angiogenesis, and cell adhesion. Forced overexpression of miR-15a/16 and miR-150 in primary fusion-positive ACC cells did not significantly alter the expression of MYB as compared with leukemic cells with MYB activation/duplication. Our data indicate that the MYB-NFIB fusion is a hallmark of ACC and that deregulation of the expression of MYB and its target genes is a key oncogenic event in the pathogenesis of ACC. Our findings also suggest that the gain-of-function activity resulting from the MYB-NFIB fusion is a candidate therapeutic target.

11 July 2008 in BMC Cell Biology
Verified
Journal Article
Open access
PDF file
MAMattias Andersson
Mattias Andersson
ASAnders Ståhlberg
Anders Ståhlberg
YAYvonne Arvidsson
Yvonne Arvidsson
AOAnita Olofsson
Anita Olofsson
HSHenrik Semb
Henrik Semb
PÅPierre Åman
Pierre Åman
FUS, EWS and TAF15 are structurally similar multifunctional proteins that were first discovered upon characterization of fusion oncogenes in human sarcomas and leukemias. The proteins belong to the FET (previously TET) family of RNA-binding proteins and are implicated in central cellular processes such as regulation of gene expression, maintenance of genomic integrity and mRNA/microRNA processing. In the present study, we investigated the expression and cellular localization of FET proteins in multiple human tissues and cell types.

27 January 2006 in Genes, Chromosomes and Cancer
Verified
Journal Article
Closed access
PDF file
ABAfrouz Behboudi
Afrouz Behboudi
FEFredrik Enlund
Fredrik Enlund
MWMarta Winnes
Marta Winnes
YAYwonne Andrén
Ywonne Andrén
ANAnders Nordkvist
Anders Nordkvist
GSGöran Stenman
Göran Stenman

3 July 2013 in Head and Neck Pathology
Verified
Journal Article
Closed access
PDF file
GSGöran Stenman
Göran Stenman

1 February 2013 in Laboratory Investigation
Verified
Journal Article
Closed access
KJKowan Ja Jee
Kowan Ja Jee
MPMarta Persson
Marta Persson
KHKristiina Heikinheimo
Kristiina Heikinheimo
FPFabricio Passador-Santos
Fabricio Passador-Santos
KAKatri Aro
Katri Aro
ILIlmo Leivo
Ilmo Leivo

16 April 2012 in Genes, Chromosomes and Cancer
Verified
Journal Article
Closed access
PDF file
MPMarta Persson
Marta Persson
YAYwonne Andrén
Ywonne Andrén
CMChristopher A. Moskaluk
Christopher A. Moskaluk
HFHenry F. Frierson
Henry F. Frierson
SCSusanna L. Cooke
Susanna L. Cooke
GSGöran Stenman
Göran Stenman